NRP1 and ovarian cancer: Ovarian cancer cells secrete IL6 and IL6Rα (soluble form sIL-6R) through trans-signaling sIL6R-IL6 in the pro-inflammatory microenvironment cells that do not express transmembrane receptor to facilitate angiogenesis via increasing the VEGF expressions [19].